Biopsy before surgery for unusual uterine growths
Part of Cancer clinical trials.
This trial looks at whether taking a small tissue sample (biopsy) before surgery can help doctors better understand unusual uterine growths that look like fibroids. If you're already planning surgery to remove such a growth, this study might help guide your treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman aged 18 or older.
- You are scheduled for surgery to remove a uterine growth (either just the growth or the whole uterus).
- You have unusual-looking fibroid-like growths seen on ultrasound.
- You are not currently pregnant, and if you've been pregnant, it was more than a year ago.
- You haven't taken hormone therapy for your uterine condition in the last 3 months.
- You haven't had uterine artery embolization or similar procedures before.
- You are willing to have an extra biopsy before surgery, done through the vagina or cervix, and you have no bleeding disorders or infections that would make it unsafe.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at lab biomarkers (signs in tumor tissue) in people with localized leiomyosarcoma. It also requires treatment with chemotherapy before surgery to see if the information from tumor samples can help guide care.
This trial uses a special needle (TRU-Cut biopsy) to take a small tissue sample from a tumor in your abdomen or pelvis. The goal is to better understand the type of cancer and help guide your treatment.
This study tests a new way to take a small tissue sample from a growth in the uterus using a thin needle through the cervix, which may help diagnose the growth before surgery. It aims to see if this method is safe and accurate.
This study tests a new way of taking a small tissue sample from a uterine fibroid using ultrasound guidance, right before your planned surgery. The sample helps doctors understand the fibroid better, and the procedure is less invasive than older methods.
This trial tests whether chemotherapy after surgery can help prevent uterine leiomyosarcoma from coming back in patients who are at high risk based on a genetic test of their tumor. It is for women with early-stage cancer (stage I) who have had complete surgery.
This trial tests whether a less invasive way to check if cancer has spread to lymph nodes (sentinel node biopsy) works as well as the standard method. It is for people with early-stage endometrial cancer having surgery.
Hear when a new Leiomyosarcoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.